Furthermore, we found lower expression levels of INPP4B were significantly corrected with poor prognosis in T‐ALL patients (Figure 6G), indicating that INPP4B may serve as a therapeutic target for T‐ALL. This evidence concerns the gene INPP4B and acute lymphoblastic leukemia.